A12298 | Pages: NA | Sep 2022 | 397 Views | ||
Author(s) : Onkar Sumant | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Molecular Cytogenetics Market
Request Now !Molecular cytogenetics encompasses different aspects of chromosome biology. The techniques and procedures to conduct molecular cytogenetics are often used in the areas of medicine and biology. Molecular cytogenetics can help study the structural and functional organization of the nucleus and the chromosome of the cell, expression, and evolution of genes, genome variation in tumor genetics, and medical genetics. The common techniques involved in molecular cytogenetics include fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and array comparative genomic hybridization (aCGH). These techniques can be used in studying cytogenetics of pre and post-natal samples and in cytogenetic testing for cancer.
Market Scope and Structure Analysis
Report Metric | Details |
 Market Size Available for Years |  2020–2030 |
 Base Year Considered |  2020 |
 Forecast Period |  2021–2030 |
 Forecast Unit |  Value (USD) |
 Segments Covered |  Product, Technique, Application, End User, and Region |
 Regions Covered |  North America, Europe, Asia-Pacific, and LAMEA |
 Companies Covered | F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Inc., Abbott Laboratories, Agilent Technologies, PerkinElmer, Inc., Illumina, Inc., Bio-Rad Laboratories, Oxford Gene Technology, and Applied Spectral Imaging |
Â
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.
With COVID-19 spreading all across the world, hospitalization rates declined dramatically. There were several reports of many hospitals operating at less than 50% capacity to curtail noncritical medical services and elective surgeries. Hospitals are even less likely to conduct molecular cytogenetics tests. Therefore, COVID 19 is expected to have a significant impact on the molecular cytogenetics market.
Top Impacting Factors
Increasing cases of cancer and related mortality growth in recent years have significantly helped expand the molecular cytogenetic market. The continued prevalence of cancer has increased the demand for advanced technologies that help understand cancer at a genomic level.
Growing pharmacogenomics activities have positively influenced the market, as many cytogenetic tools have been used over the years for pharmacogenomics biomarker studies.
Growing genetic abnormalities in many people since birth and increasing focus of healthcare systems of many countries on preventive measures for many genetic defects are some of the factors that helped augment the growth of the molecular cytogenetic market in recent years.
However, the implementation of molecular cytogenetic tools and equipment in research and clinical laboratories require high capital investments, which acts as an impeding factor of the molecular cytogenetic market.
Key Market Trends
Research & clinical laboratories segment dominated the molecular cytogenetic market in 2019, due to increasing use of cytogenetic techniques being in clinical diagnosis. Ongoing research pertaining to underlying chromosomal diseases has further enabled this segment to attain a high share in the market.
The implementation of molecular cytogenetics in biotechnology and pharmaceutical companies is expected to grow due to growing demand for targeted therapies.
North America dominates the molecular cytogenetic market, owing to high incidences of cancer and genetic disorders, high healthcare expenditure on reimbursements of health insurance, and increase in the geriatric population.
In 2016, HEALTH BioMed and Thermo Fisher Scientific, Inc. collaborated to support the development of molecular diagnostic kits from HBM. These kits are meant for pharmacogenomics screening and detection of infectious diseases.
IN 2016, Affymetrix was acquired by Thermo Fisher Scientific, Inc., which strengthened Thermo Fisher Scientific's position in the bioscience business and create new opportunities in the market for genetic analysis.
Key Segments Covered
Segment | Subsegments |
 Product |
|
 Technique |
|
 Application |
|
 End User |
|
 Region |
|
Â
Key Benefits of the Report
Questions Answered in the Molecular Cytogenetics Report
Key Market Segments
Segments | Sub-segments |
---|---|
By  Product |
|
By Technique |
|
By  Application |
|
By End User |
|
By Region |
|
Key Market Players
Loading Table Of Content...
Start reading.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers